Literature DB >> 20159435

Mucolipidosis type IV: a subtle pediatric neurodegenerative disorder.

Joseph S Geer1, Steve A Skinner, Ehud Goldin, Kenton R Holden.   

Abstract

The mucolipidoses are a heterogeneous group of autosomal recessive neurodegenerative lysosomal storage disorders. Mucolipidosis type IV is rare; it is seen predominantly in the Ashkenazi Jewish population and usually presents with global neurodevelopmental delays in infancy, subtle corneal opacifications or clouding, and very slowly progressive neurodegeneration over many years. Elevation of serum gastrin is reported; findings from x-rays of bone and joints and lysosomal studies are normal. Reported here are two cases of mucolipidosis type IV in children not of Ashkenazi Jewish origin who presented during infancy with nonspecific global psychomotor delays, generalized hypotonia, and mild corneal abnormalities, but remained undiagnosed for years. A rare gene mutation in MCOLN1 was confirmed in one of the two patients, in addition to abnormal serum gastrin levels. More striking was the length of time that these children eluded detection of their final diagnosis. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159435      PMCID: PMC2824620          DOI: 10.1016/j.pediatrneurol.2009.10.002

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  14 in total

Review 1.  Mucolipidosis type IV a rare genetic disorder: new addition to the Ashkenazi Jewish panel.

Authors:  Roxann M Gordon; Teresa Marchese
Journal:  J Midwifery Womens Health       Date:  2004 Jul-Aug       Impact factor: 2.388

2.  Mucolipidosis type IV: ganglioside sialidase deficiency.

Authors:  G Bach; M Zeigler; T Schaap; G Kohn
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

Review 3.  Mucolipidosis type IV.

Authors:  G Bach
Journal:  Mol Genet Metab       Date:  2001-07       Impact factor: 4.797

4.  Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia.

Authors:  I A Lubensky; R Schiffmann; E Goldin; M Tsokos
Journal:  Am J Surg Pathol       Date:  1999-12       Impact factor: 6.394

5.  Constitutive achlorhydria in mucolipidosis type IV.

Authors:  R Schiffmann; N K Dwyer; I A Lubensky; M Tsokos; V E Sutliff; J S Latimer; K P Frei; R O Brady; N W Barton; E J Blanchette-Mackie; E Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

6.  A variant form of mucolipidosis IV: report on 4 patients from the Indian subcontinent.

Authors:  Parayil Sankaran Bindu; Narayanappa Gayathri; Thagadur C Yasha; Jerry M E Kovoor; Ramakrishnan Subasree; Sudheendra Rao; Samhita Panda; Pramod Kumar Pal
Journal:  J Child Neurol       Date:  2008-12       Impact factor: 1.987

7.  Mucolipidosis type IV: characteristic MRI findings.

Authors:  K P Frei; N J Patronas; K E Crutchfield; G Altarescu; R Schiffmann
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

8.  Mucolipidosis type IV: clinical manifestations and natural history.

Authors:  D Chitayat; C M Meunier; K A Hodgkinson; K Silver; M Flanders; I J Anderson; J M Little; D A Whiteman; S Carpenter
Journal:  Am J Med Genet       Date:  1991-12-01

9.  Mucolipidosis type IV: clinical spectrum and natural history.

Authors:  N Amir; J Zlotogora; G Bach
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

10.  Ocular abnormalities in mucolipidosis IV.

Authors:  K G Riedel; J Zwaan; K R Kenyon; E H Kolodny; L Hanninen; D M Albert
Journal:  Am J Ophthalmol       Date:  1985-02-15       Impact factor: 5.258

View more
  8 in total

1.  Cognitive Development in a Young Child with Mucolipidosis Type IV: A Case Report.

Authors:  Evelyn L Fisher; Rose A Sevcik; MaryAnn Romski
Journal:  JIMD Rep       Date:  2017-01-03

Review 2.  Mucolipidosis type IV: an update.

Authors:  Kazuyo Wakabayashi; Ann Marie Gustafson; Ellen Sidransky; Ehud Goldin
Journal:  Mol Genet Metab       Date:  2011-06-16       Impact factor: 4.797

Review 3.  The role of TRPMLs in endolysosomal trafficking and function.

Authors:  Kartik Venkatachalam; Ching-On Wong; Michael X Zhu
Journal:  Cell Calcium       Date:  2014-10-28       Impact factor: 6.817

Review 4.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

5.  Overexpression of transient receptor potential mucolipin-2 ion channels in gliomas: role in tumor growth and progression.

Authors:  Maria Beatrice Morelli; Massimo Nabissi; Consuelo Amantini; Daniele Tomassoni; Francesco Rossi; Claudio Cardinali; Matteo Santoni; Antonietta Arcella; Maria Antonietta Oliva; Angela Santoni; Carlo Polidori; Maria Paola Mariani; Giorgio Santoni
Journal:  Oncotarget       Date:  2016-07-12

6.  Structural basis of dual Ca2+/pH regulation of the endolysosomal TRPML1 channel.

Authors:  Minghui Li; Wei K Zhang; Nicole M Benvin; Xiaoyuan Zhou; Deyuan Su; Huan Li; Shu Wang; Ioannis E Michailidis; Liang Tong; Xueming Li; Jian Yang
Journal:  Nat Struct Mol Biol       Date:  2017-01-23       Impact factor: 15.369

Review 7.  Neuropathophysiology, Genetic Profile, and Clinical Manifestation of Mucolipidosis IV-A Review and Case Series.

Authors:  Aleksandra Jezela-Stanek; Elżbieta Ciara; Karolina M Stepien
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

8.  The first genetically confirmed Japanese patient with mucolipidosis type IV.

Authors:  Harumi Saijo; Masaharu Hayashi; Takanori Ezoe; Chihiro Ohba; Hirotomo Saitsu; Kiyoko Kurata; Naomichi Matsumoto
Journal:  Clin Case Rep       Date:  2016-04-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.